Schwerpunkt auf Lebensqualität, Entzündung etc.
-
Carr, A. C., M. C. Vissers, et al. (2014). "The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life." Front Oncol 4: 283.
The Effect of Intravenous Vitamin C on Cancer- and Chemotherapy-Related Fatigue and Quality of Life
-
Ma, Y., J. Chapman, et al. (2014). "High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy." Sci Transl Med 6(222): 222ra218 (Ma, Chapman et al. 2014)
-
Tokarski, S., et al., [Assessment of the clinical symptoms and treatment tolerance in patients with non-small cell lung cancer (NSCLC) undergoing first-line chemotherapy and pulmonary rehabilitation]. Pol Merkur Lekarski, 2014. 36(214): p. 245-8. [Assessment of the clinical symptoms and treatment tolerance in patients with non-small cell lung cancer (NSCLC) undergoing first-line chemotherapy... - PubMed - NCBI
-
Takahashi, H., H. Mizuno, et al. (2012). "High-dose intravenous vitamin C improves quality of life in cancer patients." Personalized Medicine Universe 1: 49-53. High-dose intravenous vitamin C improves quality of life in cancer patients - Personalized Medicine Universe
-
Mikirova, N., J. Casciari, et al. (2012). "Effect of high-dose intravenous vitamin C on inflammation in cancer patients." J Transl Med 10: 189.
-
Mikirova, Casciari et al. 2012)
-
-
Ichim, T. E., B. Minev, et al. (2011). "Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?" J Transl Med 9: 25. (Ichim, Minev et al. 2011)
-
-
Yeom, C. H., G. C. Jung, et al. (2007). "Changes of Terminal Cancer Patients' Health-related Quality of Life after High Dose Vitamin C Administration." J Korean Med Sci 22(1): 7-11.
-
Yeom, Jung et al. 2007)
-
Schwerpunkt auf Pharmakokinetik und chemotherapeutisches Potential
· Min- Seok, S., K. Ja-Kyung and S. Jae-Yong (2015). "High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma." Yonsei Med J 2015 56: 1449-1452. High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma
·
-
Hoffer, L. J., L. Robitaille, et al. (2015). "High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial." PLoS One 10(4): e0120228.
-
Fritz, H., G. Flower, et al. (2014). "Intravenous Vitamin C and Cancer: A Systematic Review." Integr Cancer Ther 13(4): 280-300.
Intravenous Vitamin C and Cancer: A Systematic Review. - PubMed - NCBI
-
Gonzalez, M. J. and J. R. Miranda-Massari (2014). "New Insights on Vitamin C and Cancer." Springer Briefs in Cancer Research.
-
Stephenson, C. M., R. D. Levin, et al. (2013). "Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer." Cancer Chemother Pharmacol 72(1): 139-146.
-
Levine, M., S. J. Padayatty, et al. (2011). "Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries." Adv Nutr 2(2): 78-88. (Levine, Padayatty et al. 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065766/pdf/78.pdf
-
Hoffer, L. J., M. Levine, et al. (2008). "Phase I clinical trial of i.v. ascorbic acid in advanced malignancy." Ann Oncol.
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
-
Drisko, J. A., J. Chapman, et al. (2003). "The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer." J Am Coll Nutr 22(2): 118-123.
The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. - PubMed - NCBI
Experimentelle Studien
-
Uetaki, M., et al., Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress. Sci Rep, 2015. 5: p. 13896. Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress. - PubMed - NCBI
-
Huang, X.C., et al., Synergistic effects of arsenic trioxide combined with ascorbic acid in human osteosarcoma MG-63 cells: a systems biology analysis. Eur Rev Med Pharmacol Sci, 2014. 18(24): p. 3877-88. Synergistic effects of arsenic trioxide combined with ascorbic acid in human osteosarcoma MG-63 cells: a systems biology analysis. - PubMed - NCBI
-
Venturelli, S., T. W. Sinnberg, et al. (2014). "Epigenetic impacts of ascorbate on human metastatic melanoma cells." Front Oncol 4: 227.
Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells
-
Martinotti, S., et al., Combination of ascorbate/epigallocatechin-3-gallate/gemcitabine synergistically induces cell cycle deregulation and apoptosis in mesothelioma cells. Toxicol Appl Pharmacol, 2014. 274(1): p. 35-41.Combination of ascorbate/epigallocatechin-3-gallate/gemcitabine synergistically induces cell cycle deregulation and apoptosis in mesothelioma cells. - PubMed - NCBI
-
Yeom, C. H., G. Lee, et al. (2009). "High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis." J Transl Med 7: 70.
-
Yeom, Lee et al. 2009)
-
-
Chen, Q., M. G. Espey, et al. (2008). "Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice." Proc Natl Acad Sci U S A.
-
Chen, Espey et al. 2008)
-
-
Chen, Q., M. G. Espey, et al. (2005). "Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues." Proc Natl Acad Sci U S A.
(Chen, Espey et al. 2005)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224653/pdf/pnas-0506390102.pdf